Related Experiment Video
Updated: Aug 19, 2025
Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Osteopontin: An important protein in the formation of kidney stones
Qingxia Jia1,2, Ziye Huang1, Guang Wang1
1The Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Abstract:
The incidence of kidney stones averages 10%, and the recurrence rate of kidney stones is approximately 10% at 1 year, 35% at 5 years, 50% at 10 years, and 75% at 20 years. However, there is currently a lack of good medicines for the prevention and treatment of kidney stones. Osteopontin (OPN) is an important protein in kidney stone formation, but its role is controversial, with some studies suggesting that it inhibits stone formation, while other studies suggest that it can promote stone formation. OPN is a highly phosphorylated protein, and with the deepening of research, there is growing evidence that it promotes stone formation, and the phosphorylated protein is believed to have adhesion effect, promote stone aggregation and nucleation. In addition, OPN is closely related to immune cell infiltration, such as OPN as a pro-inflammatory factor, which can activate mast cells (degranulate to release various inflammatory factors), macrophages (differentiated into M1 macrophages), and T cells (differentiated into T1 cells) etc., and these inflammatory cells play a role in kidney damage and stone formation. In short, OPN mainly exists in the phosphorylated form in kidney stones, plays an important role in the formation of stones, and may be an important target for drug therapy of kidney stones.
Insights
Kidney stones affect 10% of people, with high recurrence rates. Osteopontin (OPN), a phosphorylated protein, is increasingly linked to promoting kidney stone formation and inflammation, suggesting it as a potential therapeutic target.
Area of Science:
- Nephrology
- Biochemistry
- Immunology
Background:
- Kidney stones have a high incidence (10%) and recurrence rate (up to 75% over 20 years).
- Current treatments for kidney stone prevention and management are limited.
- Osteopontin (OPN) is implicated in kidney stone formation, but its precise role remains debated.
Purpose of the Study:
- To investigate the role of Osteopontin (OPN) in kidney stone pathogenesis.
- To explore the influence of OPN phosphorylation on stone formation.
- To examine the relationship between OPN, inflammation, and kidney stone development.
Main Methods:
- Review of existing literature on Osteopontin (OPN) and kidney stone formation.
- Analysis of OPN's biochemical properties, particularly phosphorylation.
- Examination of OPN's interaction with immune cells and inflammatory pathways.
Main Results:
- Growing evidence suggests phosphorylated OPN promotes kidney stone nucleation and aggregation.
- OPN acts as a pro-inflammatory factor, activating immune cells like mast cells, macrophages, and T cells.
- Inflammatory cells activated by OPN contribute to kidney damage and stone formation.
Conclusions:
- Phosphorylated Osteopontin (OPN) plays a significant role in kidney stone formation.
- OPN's pro-inflammatory effects exacerbate kidney damage and stone development.
- OPN represents a potential therapeutic target for kidney stone treatment and prevention.
Related Concept Videos
01:28Urinary Tract Calculi I: Introduction
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
01:31Osteoclasts in Bone Remodeling
01:30Urinary Tract Calculi III: Medical Management
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...